REFERENCES
1. Chen X, Sun L, Mao Y, et al. Preoperative core needle biopsy is
accurate in determining molecular subtypes in invasive breast cancer.BMC Cancer . 2013;13:390.
2. Meattini I, Bicchierai G, Saieva C, et al. Impact of molecular
subtypes classification concordance between preoperative core needle
biopsy and surgical specimen on early breast cancer management:
Single-institution experience and review of published literature.Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol .
2017;43(4):642-648.
3. Tamaki K, Sasano H, Ishida T, et al. Comparison of core needle biopsy
(CNB) and surgical specimens for accurate preoperative evaluation of ER,
PgR and HER2 status of breast cancer patients. Cancer Sci .
2010;101(9):2074-2079.
4. Baco E, Rud E, Eri LM, et al. A Randomized Controlled Trial To Assess
and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused
Magnetic Resonance and Transrectal Ultrasound Images and Traditional
12-core Systematic Biopsy. Eur Urol . 2016;69(1):149-156.
5. Hübner N, Shariat S, Remzi M. Prostate biopsy: guidelines and
evidence. Curr Opin Urol . 2018;28(4):354-359.
6. Acord M, Shaikh R. Predictors of diagnostic success in image-guided
pediatric soft-tissue biopsies. Pediatr Radiol .
2015;45(10):1529-1534.
7. Mitton B, Seeger LL, Eckardt MA, et al. Image-guided percutaneous
core needle biopsy of musculoskeletal tumors in children. J
Pediatr Hematol Oncol . 2014;36(5):337-341.
8. Hussain HK, Kingston JE, Domizio P, Norton AJ, Reznek RH.
Imaging-guided core biopsy for the diagnosis of malignant tumors in
pediatric patients. AJR Am J Roentgenol . 2001;176(1):43-47.
9. Garrett KM, Fuller CE, Santana VM, Shochat SJ, Hoffer FA.
Percutaneous biopsy of pediatric solid tumors. Cancer .
2005;104(3):644-652.
10. Pohlig F, Kirchhoff C, Lenze U, et al. Percutaneous core needle
biopsy versus open biopsy in diagnostics of bone and soft tissue
sarcoma: a retrospective study. Eur J Med Res . 2012;17:29.
11. Weldon CB, Madenci AL, Tiao GM, et al. Evaluation of the diagnostic
biopsy approach for children with hepatoblastoma: A report from the
children’s oncology group AHEP 0731 liver tumor committee. J
Pediatr Surg . 2020;55(4):655-659.
12. Sung K-S, Seo S-W, Shon M-S. The diagnostic value of needle biopsy
for musculoskeletal lesions. Int Orthop . 2009;33(6):1701-1706.
13. Blondiaux E, Laurent M, Audureau E, et al. Factors influencing the
diagnostic yield and accuracy of image-guided percutaneous needle biopsy
of pediatric tumors: single-center audit of a 26-year experience.Pediatr Radiol . 2016;46(3):372-382.
14. Hryhorczuk AL, Strouse PJ, Biermann JS. Accuracy of CT-guided
percutaneous core needle biopsy for assessment of pediatric
musculoskeletal lesions. Pediatr Radiol . 2011;41(7):848-857.
15. Willman JH, White K, Coffin CM. Pediatric Core Needle Biopsy:
Strengths and Limitations in Evaluation of Masses. Pediatr Dev
Pathol . 2001;4(1):46-52.
16. Campagna G, Rosenfeld E, Foster J, et al. Evolving biopsy techniques
for the diagnosis of neuroblastoma in children. J Pediatr Surg .
2018;53(11):2235-2239.
17. Shin H-J, Amaral JG, Armstrong D, et al. Image-guided percutaneous
biopsy of musculoskeletal lesions in children. Pediatr Radiol .
2007;37(4):362-369.
18. Ceraulo A, Ouziel A, Lavergne E, et al. Percutaneous guided biopsy
for diagnosing suspected primary malignant bone tumors in pediatric
patients: a safe, accurate, and cost-saving procedure. Pediatr
Radiol . 2017;47(2):235-244.
19. Saarinen UM, Wikström S, Koskimies O, Sariola H. Percutaneous needle
biopsy preceding preoperative chemotherapy in the management of massive
renal tumors in children. J Clin Oncol Off J Am Soc Clin Oncol .
1991;9(3):406-415.
20. Wang H, Li F, Liu J, Zhang S. Ultrasound-guided core needle biopsy
in diagnosis of abdominal and pelvic neoplasm in pediatric patients.Pediatr Surg Int . 2014;30(1):31-37.
21. Dykes EH, Marwaha RK, Dicks-Mireaux C, et al. Risks and benefits of
percutaneous biopsy and primary chemotherapy in advanced Wilms’ tumour.J Pediatr Surg . 1991;26(5):610-612.
22. Ilivitzki A, Abugazala M, Arkovitz M, et al. Ultrasound-guided core
biopsy as the primary tool for tissue diagnosis in pediatric oncology.J Pediatr Hematol Oncol . 2014;36(5):333-336.
23. Didolkar MM, Anderson ME, Hochman MG, et al. Image guided core
needle biopsy of musculoskeletal lesions: are nondiagnostic results
clinically useful? Clin Orthop . 2013;471(11):3601-3609.
24. Peer S, Freuis T, Loizides A, Gruber H. Ultrasound guided core
needle biopsy of soft tissue tumors; a fool proof technique? Med
Ultrason . 2011;13(3):187-194.
25. Noebauer-Huhmann I-M, Amann G, Krssak M, et al. Use of diagnostic
dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour
biopsies at 3T: preliminary results. Eur Radiol .
2015;25(7):2041-2048.
26. Dupuy DE, Rosenberg AE, Punyaratabandhu T, Tan MH, Mankin HJ.
Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms.AJR Am J Roentgenol . 1998;171(3):759-762.
27. Overman RE, Kartal TT, Cunningham AJ, et al. Optimization of
percutaneous biopsy for diagnosis and pretreatment risk assessment of
neuroblastoma. Pediatr Blood Cancer . 2020;67(5).
28. Wang Z, Shi H, Zhang X, Pan J, Jin Z. Value of CT-guided
percutaneous needle biopsy of bone in the diagnosis of lymphomas based
on PET/CT results. Cancer Imaging Off Publ Int Cancer Imaging
Soc . 2019;19(1):42.
29. Wu M, Xiao L, Liu H, et al. PET/CT-guided versus CT-guided
percutaneous core biopsies in the diagnosis of bone tumors and
tumor-like lesions: which is the better choice? Cancer Imaging .
2019;19(1):69.
30. Taupin T, Decouvelaere A-V, Vaz G, Thiesse P. Accuracy of core
needle biopsy for the diagnosis of osteosarcoma: A retrospective
analysis of 73patients. Diagn Interv Imaging . 2016;97(3):327-331.
31. Loizides A, Widmann G, Freuis T, Peer S, Gruber H. Optimizing
ultrasound-guided biopsy of musculoskeletal masses by application of an
ultrasound contrast agent. Ultraschall Med Stuttg Ger 1980 .
2011;32(3):307-310.
32. Bettati P, Chalian M, Huang J, Dormer JD, Shahedi M, Fei B.
Augmented Reality-Assisted Biopsy of Soft Tissue Lesions. Proc
SPIE– Int Soc Opt Eng . 2020;11315.
33. Ambros PF, Ambros IM, Brodeur GM, et al. International consensus for
neuroblastoma molecular diagnostics: report from the International
Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer .
2009;100(9):1471-1482.
34. Lodrini M, Sprüssel A, Astrahantseff K, et al. Using droplet digital
PCR to analyze MYCN and ALK copy number in plasma from patients with
neuroblastoma. Oncotarget . 2017;8(49):85234-85251.
35. Somasundaram DB, Aravindan S, Yu Z, et al. Droplet digital PCR as an
alternative to FISH for MYCN amplification detection in human
neuroblastoma FFPE samples. BMC Cancer . 2019;19(1):106.
36. Steliarova-Foucher E, Fidler MM, Colombet M, et al. Changing
geographical patterns and trends in cancer incidence in children and
adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information
System): a population-based study. Lancet Oncol .
2018;19(9):1159-1169.
37. Nakata K, Ito Y, Magadi W, et al. Childhood cancer incidence and
survival in Japan and England: A population-based study (1993-2010).Cancer Sci . 2018;109(2):422-434.
38. Park HJ, Moon E-K, Yoon JY, et al. Incidence and Survival of
Childhood Cancer in Korea. Cancer Res Treat Off J Korean Cancer
Assoc . 2016;48(3):869-882.
39. Tulla M, Berthold F, Graf N, et al. Incidence, Trends, and Survival
of Children With Embryonal Tumors. Pediatrics .
2015;136(3):e623-632.
40. Shinagawa T, Kitamura T, Katanoda K, Matsuda T, Ito Y, Sobue T. The
incidence and mortality rates of neuroblastoma cases before and after
the cessation of the mass screening program in Japan: A descriptive
study. Int J Cancer . 2017;140(3):618-625.
41. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors of
Infancy: An Overview. Pediatr Rev . 2018;39(2):57-67.
LEGENDS
Figure 1 Flowchart of patient selection